SEC Form 4 · accession 0001213900-18-002139

LifeMD, Inc. · LFMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Feb 13, 2018

Accepted (ET)

Feb 20, 2018 · 8:00 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000948320

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock, par value $0.01^F1	Feb 13, 2018	D	1,130,436	$0.23	D	2,640,507	D
Common Stock, par value $0.01^F4	Feb 13, 2018	S	298,407	$0.23	D	2,342,100	D
Common Stock, par value $0.01^F3	Feb 13, 2018	S	100,000	$0.23	D	1,040,000	I	McLaughlin International, Inc.
Common Stock, par value $0.01^F2,F4	Feb 13, 2018	S	190,000	$0.23	D	54,228	I	Bruni McLaughlin - Spouse
Common Stock, par value $0.01^F1,F2	Feb 13, 2018	D	217,391	$0.23	D	512,284	I	Genevieve McLaughlin - Daughter
Common Stock, par value $0.01^F2,F5	Feb 13, 2018	S	5,504	$0.23	D	506,780	I	Genevieve McLaughlin - Daughter
Common Stock, par value $0.01^F1,F2	Feb 13, 2018	D	217,391	$0.23	D	553,284	I	James McLaughlin - Son
Common Stock, par value $0.01^F2,F4	Feb 13, 2018	S	15,000	$0.23	D	538,284	I	James McLaughlin - Son
Common Stock, par value $0.01^F2,F5	Feb 13, 2018	S	31,504	$0.23	D	506,780	I	James McLaughlin - Son
Common Stock, par value $0.01^F1,F2	Feb 13, 2018	D	217,391	$0.23	D	538,362	I	Mark McLaughlin Jr. - Son
Common Stock, par value $0.01^F1,F2,F5	Feb 13, 2018	S	31,582	$0.23	D	506,780	I	Mark McLaughlin Jr. - Son
Common Stock, par value $0.01^F1,F2	Feb 13, 2018	D	217,391	$0.23	D	634,784	I	Faith McLaughlin - Daughter
Common Stock, par value $0.01^F2,F4	Feb 13, 2018	S	96,593	$0.23	D	538,191	I	Faith McLaughlin - Daughter
Common Stock, par value $0.01^F2,F5	Feb 13, 2018	S	31,410	$0.23	D	506,781	I	Faith McLaughlin - Daughter

No Table II lines on this filing.

F1As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share.
F2The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F3The Reporting Persons beneficially owns shares through a company owned together with his spouse.
F4These shares were sold in a private transaction to JOJ Holdings, Inc., an entity affiliated with Immudyne's President and Chief Executive Officer, Justin Schreiber, in connection with the transactions contemplated by the Legacy Assets Sale Agreement.
F5These shares were sold in private transactions in connection with the transactions contemplated by the Legacy Assets Sale Agreement.